CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Internet-delivered cognitive behavior therapy (ICBT) for dysfunctional worry related to the Covid-19 pandemicWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)


Name (Synonyms) Correlation
drug1521 Moxibustion plus Cupping Wiki 1.00

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D003289 Convalescence NIH 0.45

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Evaluation of a Brief Online-delivered Cognitive-behavioral Intervention for Dysfunctional Worry Related to the Covid-19 Pandemic: A Randomized Controlled Trial

The purpose of this study is to investigate if a brief online-delivered cognitive-behavioral intervention can reduce the degree of dysfunctional worry related to the Covid-19 pandemic, compared to a wait-list control condition.

NCT04341922 Dysfunctional Worry Behavioral: Internet-delivered cognitive behavior therapy (ICBT) for dysfunctional worry related to the Covid-19 pandemic

Primary Outcomes

Description: A 7-item self-rated scale to assess symtom severity of worry. Total score ranging from 0 to 21. Effects will be expressed as the change from baseline to last post-treatment value (Week 0-Week 3) period. Effects will also be assessed at one month and one year post-treatment.

Measure: • Covid-19-adapted version of the self-rated Generalized Anxiety Disorder Scale-7 (GAD-7)

Time: Basline (week 0), during treatment (week 1 and week 2), post treatment (week 3), at one-month after treatment and also one year follow up.

Secondary Outcomes

Description: A 9-item self-rated scale to assess symtoms of depression.Total score ranging from 0 to 54.

Measure: Montgomery Åsberg Depression Rating Scale - Self report (MADRS-S)

Time: Baseline (week 0), post treatment (week 3), at one-month after treatment and also one year follow up.

Description: A 5-item self-rated scale adapted to measure impact of the Covid-19 pandemic on work and social functioning. Total score ranging from 0 to 40.

Measure: Adapted Covid-19 version of the Work and Social Adjustment Scale (WSAS)

Time: Basline (week 0), during treatment (week 1 and week 2), post treatment (week 3), at one-month after treatment and also one year follow up.

Description: A 7-item self-rated scale to asess severity of insomnia symtoms. Total score ranging from 0 to 28.

Measure: Insomnia Severity Index (ISI)

Time: Baseline (week 0), post treatment (week 3), at one-month after treatment and also one year follow up.

Description: A self-rated scale to assess Coronavirus/covid-19 health/exposure status, life changes, changes in daily behaviors, impact on emotions/worries, changes in media use past two weeks and changes in substance use due to coronavirus/covid-19 crisis. The scale has bees translated to Swedish and adopted to a Swedish context.

Measure: Adapted Swedish version of the CoRonavIruS Health Impact Survey (CRISIS)

Time: Baseline (week 0), post treatment (week 3), at one-month after treatment and also one year follow up.

Description: A 12-item self-rated scale to assess intolerance of uncertainty. Total score ranging from 12 to 60.

Measure: Intolerance of uncertainty Scale (IUS)

Time: Baseline (week 0), post treatment (week 3), at one-month after treatment and also one year follow up.

Description: A self-rated scale to assess treamtent satisfaction.

Measure: Patient Satisfaction Questionnaire (PSQ)

Time: Post treatment (week 3)

Description: A self-rated questionnaire with free text options to assess adverse events du to the intervention.

Measure: Adverse events (AE)

Time: Post treatment (week 3)


No related HPO nodes (Using clinical trials)